- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Indian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
8
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
8 companies
Abbott India
Market Cap: ₹731.5b
Operates as a pharmaceutical company in India.
500488
₹34,422.60
7D
-0.6%
1Y
21.2%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹535.0b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,158.15
7D
-0.06%
1Y
14.6%
AstraZeneca Pharma India
Market Cap: ₹229.6b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,182.30
7D
1.8%
1Y
30.0%
Indegene
Market Cap: ₹130.3b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹543.00
7D
-2.5%
1Y
-8.5%
RPG Life Sciences
Market Cap: ₹39.7b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,401.00
7D
-4.6%
1Y
21.4%
Alpa Laboratories
Market Cap: ₹2.1b
Engages in the manufacture and sale of pharmaceutical finished dosage forms in India.
ALPA
₹101.01
7D
-3.1%
1Y
7.4%
Par Drugs and Chemicals
Market Cap: ₹1.3b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹102.65
7D
-8.7%
1Y
-56.6%
Amwill Health Care
Market Cap: ₹1.2b
A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.
544353
₹60.30
7D
-9.7%
1Y
n/a